| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Apr―04 |
Reader Comment Regarding “Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: A Scoping and Narrative Review” |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 2 |
[GO] |
2023―Feb―22 |
Chilblain-Like Lesions (CLL) Coinciding With the SARS-CoV-2 Pandemic in Children: A Systematic Review |
Samantha Y. Starkey, Nadia Kashetsky, Joseph M. Lam, Jan Dutz, Ilya M. Mukovozov |
| 3 |
[GO] |
2023―Feb―15 |
Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review |
Farhan Mahmood, Janelle Cyr, Amy Li, Jennifer Lipson, Melanie Pratt, Jennifer Beecker |
| 4 |
[GO] |
2022―Dec―06 |
Under-Reporting of COVID-19 Infections in Psoriasis Patients on Biologics |
Katrina Cirone, Ronald Vender |
| 5 |
[GO] |
2022―Dec―06 |
Successful Use of Percutaneous Dissolvable Sutures During COVID-19 Pandemic: A Retrospective Review |
Joshua Gallop, Wyatt Andrasik, Jennifer Lucas |
| 6 |
[GO] |
2022―Nov―21 |
Alopecia Areata as a Sequela of COVID-19 Vaccination: A Systematic Review |
Elena Pastukhova, Heidi Oi-Yee Li, Olivier Brandts-Longtin, Mark G. Kirchhof |
| 7 |
[GO] |
2022―Jul―13 |
The Impact of the COVID-19 Pandemic on the Canadian Dermatology Residency Match |
Janis Chang, Carly Kirshen |
| 8 |
[GO] |
2021―Nov―16 |
Impact of the COVID-19 Pandemic on Canadian Dermatology Residents: A Cross Sectional Survey Study |
E. Dimitra Bednar, Philip R. Doiron, Mohannad Abu-Hilal |
| 9 |
[GO] |
2021―Oct―19 |
COVID-19 Skin Manifestations in Skin of Colour |
Edgar Akuffo-Addo, Mathew N. Nicholas, Marissa Joseph |
| 10 |
[GO] |
2021―Sep―30 |
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study |
Abrahim Abduelmula, Jorge R. Georgakopoulos, Asfandyar Mufti, Alim R. Devani, Melinda J. Gooderham, Chih-Ho Hong, Vipul Jain, Perla Lansang, Ronald Vender, Vimal H. Prajapati, Jensen Yeung |
| 11 |
[GO] |
2021―Sep―23 |
Teledermatology Utilization and Integration in Residency Training Over the COVID-19 Pandemic |
Farhan Mahmood, Janelle Cyr, Erin Keely, Amir Afkham, Sheena Gugiani, Jim Walker, Jean-Pierre DesGroseilliers, Carly Kirshen |
| 12 |
[GO] |
2021―Jul―29 |
An Added Benefit of Masks During the COVID-19 Pandemic: Ultraviolet Protection |
Valerie C. Doyon, Touraj Khosravi-Hafshejani, Vincent Richer |
| 13 |
[GO] |
2021―Jul―07 |
Delayed Cutaneous Reactivity Associated With COVID-19 Vaccines Is Rare |
Farhan Mahmood, Anastasiya Muntyanu, Catherine Besner Morin, Ivan Litvinov, Ghislaine Annie C. Isabwe, Elena Netchiporouk |
| 14 |
[GO] |
2021―Jun―10 |
Continuation and Discontinuation Rates of Biologics in Dermatology Patients During COVID-19 Pandemic |
Stephanie R. Cohen, Jared S. Kahn, David X. Gao, Kristin Fiumara, Anh Lam, Nicole Dumont, David Rosmarin |
| 15 |
[GO] |
2021―May―03 |
Impact of COVID-19 on Access to Care: A National Patient Survey |
Sheida Naderi-Azad, Rachael Manion, Raed Alhusayen |
| 16 |
[GO] |
2021―Apr―14 |
Chilblain-Like Lesions (CLL) Associated With COVID-19 (“COVID Toes”): A Systematic Review |
Nadia Kashetsky, Ilya M. Mukovozov, James Bergman |
| 17 |
[GO] |
2021―Feb―24 |
Impact of Treatment With TNF-α Inhibitors for Hidradenitis Suppurativa During the COVID-19 Pandemic |
Gabrielle Benesh, Tyler M. Andriano, Kayla M. Babbush, H. Dean Hosgood, Steven R. Cohen |
| 18 |
[GO] |
2021―Feb―24 |
Response to Reader Comment Regarding “Approach to Chilblains During the COVID-19 Pandemic” |
Malika A. Ladha, Nadia Luca, Cora Constantinescu, Karen Naert, Michele L. Ramien |
| 19 |
[GO] |
2021―Feb―24 |
Reader Comment Regarding “Approach to Chilblains During the COVID-19 Pandemic” |
Ana E. López-Sundh, C. Gómez-Fernández, Marcos A. González-López |
| 20 |
[GO] |
2021―Feb―17 |
Medical Student and Resident Dermatology Education in Canada During the COVID-19 Pandemic |
Malika A. Ladha, Harvey Lui, Julia Carroll, Philip Doiron, Carly Kirshen, Aaron Wong, Kerri Purdy |
| 21 |
[GO] |
2021―Jan―28 |
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic |
Heather Le, Ronald B. Vender |
| 22 |
[GO] |
2020―Nov―12 |
Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 can be Divided Into Inflammatory and Vascular Patterns |
Sheida Naderi-Azad, Ron Vender |
| 23 |
[GO] |
2020―Sep―16 |
Impacts of COVID-19 on Dermatologic Practice, Disease Presentation, and Immunomodulator Prescriptions |
Maria Leis, Patrick Fleming, Charles W. Lynde |
| 24 |
[GO] |
2020―Aug―06 |
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis |
Matthew Ladda, Charles Lynde, Patrick Fleming |
| 25 |
[GO] |
2020―Aug―05 |
Skin Damage Prevention Strategies During COVID-19: Assessing Their Effect on N95 Mask Seal Integrity |
Perla Lansang, Kelsey A. Orrell, Jennifer Tran, Tiffany Chen |
| 26 |
[GO] |
2020―Aug―03 |
Approach to Chilblains During the COVID-19 Pandemic |
Malika A. Ladha, Nadia Luca, Cora Constantinescu, Karen Naert, Michele L. Ramien |
| 27 |
[GO] |
2020―Jun―17 |
Impact of COVID-19 on Patient-Initiated Discontinuation of Omalizumab in Two Academic Hospital Clinics at the University of Toronto |
Jason Ho Seung Kim, Jorge R. Georgakopoulos, Jensen Yeung |
| 28 |
[GO] |
2020―Jun―01 |
Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto |
Jorge R. Georgakopoulos, Jensen Yeung |
| 29 |
[GO] |
2020―May―25 |
Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes |
David Nassim, Abdulhadi Jfri, Ivan V. Litvinov, Elena Netchiporouk |
| 30 |
[GO] |
2020―May―21 |
Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic |
Giuseppe Ferrara, Daniel Morgado-Carrasco |
| 31 |
[GO] |
2020―May―21 |
Patient-Driven Discontinuation of Dupilumab During the COVID-19 Pandemic in Two Academic Hospital Clinics at the University of Toronto |
Jorge R. Georgakopoulos, Jensen Yeung |
| 32 |
[GO] |
2020―May―12 |
Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice |
Jorge R. Georgakopoulos, Ron Vender, Jensen Yeung |
| 33 |
[GO] |
2020―May―11 |
Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far? |
Stephanie Ghazal, Ivan V. Litvinov, Naif Aljahani, Abdulhadi Jfri, Elena Netchiporouk |
